(VIANEWS) – Digital Ally (DGLY), Duke Realty Corporation (DRE), Amphastar Pharmaceuticals (AMPH) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Digital Ally (DGLY)

370.7% sales growth and 72.72% return on equity

Digital Ally, Inc. manufactures and sells digital storage, disinfectant, and video imaging products. These safety products can be used in security, law enforcement, and other commercial purposes in the United States as well as internationally.

Digital Ally’s sales growth this year is expected to be 146.8% and 13.6% for next year.

Year-on-year quarterly revenue growth grew by 324.2%, now sitting on 21.41M for the twelve trailing months.

Volume

Today’s last reported volume for Digital Ally is 123523 which is 70.18% below its average volume of 414255.

Digital Ally’s sales growth for the next quarter is 370.7%. The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and 40%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 72.72%.

Volatility

Digital Ally’s last day, last week, and last month’s current intraday variation average was 1.35%, 1.06%, and 1.05%, respectively.

Digital Ally’s highest amplitude of average volatility was 5.48% (day), 3.48% (last week), and 3.40% (last month), respectively.

Digital Ally’s Stock Yearly Top and Bottom Value

Digital Ally’s stock is valued at $0.77 at 20:22 EST, way under its 52-week high of $1.65 and above its 52-week low of $0.72.

Digital Ally’s Moving Average

Digital Ally’s value is below its 50-day moving average of $0.85 and way under its 200-day moving average of $1.04.

2. Duke Realty Corporation (DRE)

23.6% sales growth and 16.09% return on equity

Duke Realty Corporation manages approximately 156,000,000 square feet of rentable industrial property in 20 large logistics markets.

Duke Realty Corporation’s sales growth this year is anticipated to be 19.3% and 11.3% for next year.

Year-on-year quarterly revenue growth grew by 5.3%, now sitting on 1.12B for the twelve trailing months.

Volume

Today’s last reported volume for Duke Realty Corporation is 1513090 which is 54.83% below its average volume of 3350280.

Duke Realty Corporation’s sales growth is a negative 0% for the current quarter and 23.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 80.9% and negative -8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.09%.

Volatility

Duke Realty Corporation’s last day, last week, and last month’s current intraday variation average was 1.39%, 0.65%, and 1.19%, respectively.

Duke Realty Corporation’s highest amplitude of average volatility was 1.81% (day), 2.17% (last week), and 2.30% (last month), respectively.

Duke Realty Corporation’s Stock Yearly Top and Bottom Value

Duke Realty Corporation’s stock is valued at $62.68 at 20:22 EST, under its 52-week high of $66.22 and way higher than its 52-week low of $47.12.

Duke Realty Corporation’s Moving Average

Duke Realty Corporation’s value is way above its 50-day moving average of $56.07 and above its 200-day moving average of $57.04.

3. Amphastar Pharmaceuticals (AMPH)

14% sales growth and 14.16% return on equity

Amphastar Pharmaceuticals, Inc., is a specialty pharmaceutical firm that develops, manufactures, market and sells intranasal, injectable, and inhalation products. It operates in France, China, the United States, and France.

Amphastar Pharmaceuticals’s sales growth this year is expected to be 14.4% and 9.1% for next year.

Year-on-year quarterly revenue growth grew by 26%, now sitting on 437.77M for the twelve trailing months.

Volume

Today’s last reported volume for Amphastar Pharmaceuticals is 204210 which is 63.68% below its average volume of 562385.

Amphastar Pharmaceuticals’s sales growth is a negative 0% for the present quarter and 14% for the next. The company’s growth estimates for the current quarter and the next is 71.4% and negative -10.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.16%.

Volatility

Amphastar Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 0.65%, 1.56%, and 2.01%, respectively.

Amphastar Pharmaceuticals’s highest amplitude of average volatility was 2.15% (day), 2.78% (last week), and 3.98% (last month), respectively.

Amphastar Pharmaceuticals’s Stock Yearly Top and Bottom Value

Amphastar Pharmaceuticals’s stock is valued at $37.12 at 20:22 EST, way below its 52-week high of $44.46 and way above its 52-week low of $17.56.

Amphastar Pharmaceuticals’s Moving Average

Amphastar Pharmaceuticals’s worth is higher than its 50-day moving average of $34.99 and way above its 200-day moving average of $28.99.

4. First Business Financial Services (FBIZ)

9% sales growth and 15.1% return on equity

First Business Financial Services, Inc. is the bank holding firm for First Business Bank. It provides services and products in commercial banking for business owners, small- and medium-sized companies, professional and wealthy individuals.

First Business Financial Services’s sales growth this year is expected to be 6.3% and 9.2% for next year.

Year-on-year quarterly revenue growth declined by 1.5%, now sitting on 118.11M for the twelve trailing months.

Volume

Today’s last reported volume for First Business Financial Services is 34472 which is 39.09% below its average volume of 56604.

First Business Financial Services’s sales growth is a negative 0% for the current quarter and 9% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 13.1% and negative -5.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.1%.

Volatility

First Business Financial Services’s last day, last week, and last month’s current intraday variation average was 2.97%, 1.10%, and 1.08%, respectively.

First Business Financial Services’s highest amplitude of average volatility was 4.80% (day), 2.17% (last week), and 2.05% (last month), respectively.

First Business Financial Services’s Stock Yearly Top and Bottom Value

First Business Financial Services’s stock is valued at $33.23 at 20:22 EST, below its 52-week high of $35.92 and way higher than its 52-week low of $26.57.

First Business Financial Services’s Moving Average

First Business Financial Services’s value is higher than its 50-day moving average of $32.43 and above its 200-day moving average of $31.68.

5. Canadian National Railway Company (CNI)

6.1% sales growth and 23.01% return on equity

Canadian National Railway Company and its affiliates are involved in rail transportation.

Canadian National Railway Company’s sales growth this year is anticipated to be 6.4% and 7.8% for next year.

Year-on-year quarterly revenue growth grew by 5.3%, now sitting on 14.38B for the twelve trailing months.

Volume

Today’s last reported volume for Canadian National Railway Company is 878560 which is 35.02% below its average volume of 1352210.

Canadian National Railway Company’s sales growth is a negative 0% for the ongoing quarter and 6.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 15% and 9.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.01%.

Volatility

Canadian National Railway Company’s last day, last week, and last month’s current intraday variation average was 0.87%, 0.50%, and 1.17%, respectively.

Canadian National Railway Company’s highest amplitude of average volatility was 1.29% (day), 1.49% (last week), and 1.79% (last month), respectively.

Canadian National Railway Company’s Stock Yearly Top and Bottom Value

Canadian National Railway Company’s stock is valued at $126.28 at 20:22 EST, below its 52-week high of $136.22 and way above its 52-week low of $100.66.

Canadian National Railway Company’s Moving Average

Canadian National Railway Company’s worth is under its 50-day moving average of $127.60 and above its 200-day moving average of $115.25.

LEAVE A REPLY

Please enter your comment!
Please enter your name here